FDA Adverse Event Malfunction Summary report: N

1823260-2015-04499

MDR report key: 5213649 · Received November 10, 2015

Report

Report Number
1823260-2015-04499
Event Type
Malfunction
Date Received
November 10, 2015
Date of Event
October 20, 2015
Report Date
December 2, 2015
PMA / PMN Number
K060373
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

BASED ON A REVIEW OF THE ALARM TRACE, THERE IS NO INDICATION OF AN INSTRUMENT ISSUE AT THE TIME OF THE ERRONEOUS RESULTS. CALIBRATION AND QUALITY CONTROLS WERE ACCEPTABLE. THE ANALYZER PERFORMANCE CHECK WAS ACCEPTABLE. A POSSIBLE ROOT CAUSE MAY BE RELATED TO ELECTROMAGNETIC INTERFERENCE AS THE COUNT DIFFERENCES ARE LOW AND THERE ARE 5 CENTRIFUGES LOCATED DIRECTLY NEXT TO THE INSTRUMENT.

Additional Manufacturer Narrative · 1

THE FIELD SERVICE ENGINEER PROVIDED PHOTOS SHOWING WHERE THE LABORATORY CENTRIFUGES ARE POSITIONED IN RELATION TO THE E 601 ANALYZER. A POSSIBLE ROOT CAUSE MAY BE AN ELECTROMAGNETIC INTERFERENCE.

Additional Manufacturer Narrative · 1

THIS EVENT OCCURRED IN (B)(6). (B)(4). (B)(6).

Description of Event or Problem · 1

THE CUSTOMER QUESTIONED RESULTS FROM 2 SAMPLES FOR ONE PATIENT IN THE EMERGENCY ROOM WHO WAS TESTED FOR TROPONIN T HS (HIGH SENSITIVE) TROPONIN T HS. OF THE DATA PROVIDED, THE RESULTS FOR ONE SAMPLE WERE ERRONEOUS AND REPORTED OUTSIDE OF THE LABORATORY. THE INITIAL TROPONIN T HS RESULT AT 11:25 A.M. WAS 24.76 NG/L. THIS RESULT WAS REPORTED OUTSIDE OF THE LABORATORY. A 2ND SAMPLE WAS OBTAINED AT 4:22 P.M. AND THE RESULT WAS 5.61 NG/L. AT THIS POINT, THE LABORATORY TECHNICIAN DECIDED TO REPEAT BOTH SAMPLES. THE INITIAL SAMPLE WAS REPEATED AT 5:33 P.M. AND THE RESULT WAS 3.95 NG/L. THE 2ND SAMPLE WAS REPEATED AT 5:21 P.M. AND THE RESULT WAS 5.67 NG/L. THE REPEAT RESULTS WERE CONSIDERED TO BE CORRECT. NO ADVERSE EVENT OCCURRED. THE TROPONIN T HS REAGENT LOT NUMBER WAS 181799. THE EXPIRATION DATE WAS NOT PROVIDED.

Patients

Seq Age Sex Outcome Treatment
1 045 YR